All going well MSB will be already established in the market...

All going well MSB will be already established in the market place by the time the effectiveness of CYP's stem cells are proven to be effective and safe.  


http://www.********.au/2015/02/20/is-cynata-therapeutics-ltd-set-for-blockbuster-returns/

According to the announcement, the Cymerus process can develop an effectively infinite number of mesynchmal stem cells for therapeutic use from an ‘induced pluripotent stem cell’ (iPSC) bank – derived from a single blood donation – which means there will be no need to repeatedly source, screen and test new donors and tissues.

This will dramatically lower costs compared to existing methods, and there should also be significant financial advantage to owning a ‘world first’ stem cell manufacturing process.

However investors should beware of getting too excited, since the actual effectiveness of MSC cells in treatment has yet to be fully validated, and clinical trials are only in the early stages of planning.

Phase 1 clinical trials – out of a potential three time consuming and expensive Phases – are only in the planning stage, and the full evaluation of any new treatment generally takes several years from Phase 1 to full regulatory approval.